Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Page 8 of 22.

Strong sales growth and further margin improvements – important acquisition to accelerate the US extremities business

  • Total net sales increased by 24.8% year-on-year at CER[1]
  • All regions grew by more than 20% CER – 29% growth in the US and 22% in EMEA
  • Strong growth led to higher margins at all levels – EBITDA...
Read more

Medartis 2021 full-year results presentation

Dear ladies and gentlemen

We are pleased to invite you to our FY 2021 results presentation on 7 March 2022. We will publish our media release, the Annual Report, and the conference presentation on...

Read more

Medartis Holding AG | Invitation Media and Investor conference | 2021 annual results

We are pleased to invite you to our FY 2021 results presentation on 7 March 2022. We will publish our media release, the Annual Report, and the conference presentation on our corporate website and...

Read more

Page 8 of 22.